𝗪𝗵𝘆 𝗜 𝗮𝗱𝗱𝗲𝗱 𝗥𝗼𝘆𝗮𝗹 𝗗𝘂𝘁𝗰𝗵 𝗦𝗵𝗲𝗹𝗹 𝘁𝗼 𝗺𝘆 𝗽𝗼𝗿𝘁𝗳𝗼𝗹𝗶𝗼

Dear Copiers&Followers, As some of you know my Global Leaders Portfolio (GLP) has pretty strict rules of picking stocks and other assets to it that alltogether are called Smart Investing Approach (SIA). 𝗦𝗜𝗔𝗦𝗰𝗼𝗿𝗲 As for stocks specifically I use a set of 5 points that I call SIAScore. Here they are: S1: growing sector 1pts/0pts,…

✅ Rechecking investment story for $SEDG ✅

Dear Followers&Copiers, In this post I run a fundamental update for $SEDG, which “together with its subsidiaries, designs, develops, and sells direct current (DC) optimized inverter systems for solar photovoltaic (PV) installations worldwide. It offers inverters, power optimizers, communication devices, and smart energy management solutions used in residential, commercial, and small utility-scale solar installations; and…

✅ A quick look at $AAPL (Apple) ✅

Dear Followers&Copiers, In this post I run a fundamental update for $AAPL, which “designs, manufactures and markets mobile communication and media devices, personal computers and portable digital music players. The Company sells a range of related software, services, accessories, networking solutions, and third-party digital content and applications. The Company’s segments include the Americas, Europe, Greater…

✅ 𝗙𝗮𝗰𝗲𝗯𝗼𝗼𝗸 𝗶𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝘀𝘁𝗼𝗿𝘆 𝘂𝗽𝗱𝗮𝘁𝗲 ✅

Dear Followers&Copiers, In this post I run a fundamental/technical investment update for $FB (Facebook), which “is focused on building products that enable people to connect and share through mobile devices, personal computers and other surfaces. The Company’s products include Facebook, Instagram, Messenger, WhatsApp and Oculus. Facebook enables people to connect, share, discover and communicate with…

✅ $BIIB – a pharma company with potential ✅

Dear Followers&Copiers, In this post I run a SIAScore update for $BIIB, which “is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for…